reports
Cellectar Biosciences Reports Financial Results for Q3 2024 and Provid...
Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update Phase 2 CLOVER-WaM pivotal study data selected for oral presentation at 66th Annual American Society of Hematology Meeting and Exposition Raised approximately $19.4 million with potential to raise up to an additional $73.3 million Company to hold webcast and conference call at 8:30 AM ET today FLORHAM PARK, N.J., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercializati...
Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Par...
Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225 NorthStar to provide Cellectar with non-carrier-added Ac-225 for its expanded portfolio of clinical programs FLORHAM PARK, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB) a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced the signing of a strategic supply agreement with NorthStar Medical Radioisotopes, LLC, for the procurement of NorthStar’...
Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phos...
Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer Cellectar broadens global manufacturing network in preparation for potential commercialization of Iopofosine I 131 in 2025 INDIANAPOLIS and FLORHAM PARK, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- a leading radiopharmaceutical contract developer and manufacturer, and , a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, have signed a commercial supply agreement for the manufac...
Cellectar Biosciences to Report Third Quarter Financial Results and Ho...
Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024 FLORHAM PARK, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that the company will report financial results for the three months ended September 30, 2024, and provide a corporate update on November 18, 2024, at 8:30 a.m. Eastern Time. Conference Call & Webcast Details:Date:Mo...
Cellectar Biosciences Inc: 1 director
A director at Cellectar Biosciences Inc bought 25,000 shares at 1.040USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
- Jonathan Moreland
REI RING ENERGY INC.
PBF PBF ENERGY INC. CLASS A
LXRX LEXICON PHARMACEUTICALS INC.
LOB LIVE OAK BANCSHARES
LNDC LANDEC CORP.
INTC INTEL CORPORATION
GTIM GOOD TIMES RESTAURANTS INC
CTMX CYTOMX THERAPEUTICS INC.
CLR CONTINENTAL RESOURCES INC.
ALDX ALDEYRA THERAPEUTICS
ADVM ADVERUM BIOTECHNOLOGIES
CQP CHENIERE ENERGY PARTNERS L.P.
MBII MARRONE BIO INNOVATIONS INC
AIRT AIR T INC.
UIHC UNITED INSURANCE HOLDINGS CORP.
CNBKA CENTURY BANCORP INC. CL A
PLSE PULSE BIOSCIENCES
SPLP STEEL PARTNERS HOLDINGS LP LTD.
GBDC GOLUB CAPITAL BDC INC.
MRUS MERUS B V
OCX ONCOCYTE
REVG REV GROUP INC.
ESTE EARTHSTONE ENERGY
CLRB CELLECTAR BIOSCIENCES
BRN BARNWELL INDUSTRIES
ODT ODONATE THERAPEUTICS INC
MBIO MUSTANG BIO
KRMD REPRO MED SYSTEMS
GIM TEMPLETON GLOBAL INCOME FUND
GTXMQ GARRETT MOTION INC.
ARVN ARVINAS HOLDING
VTA INVESCO DYNAMIC CREDIT OPPORTU
KFS KINGSWAY FINANCIAL SERVICES
USIO USIO INC
BW BABCOCK & WILCOX ENTERPRISES
LSYN LIBERATED SYNDICATION
TCON TRACON PHARMACEUTICALS
DMTK DERMTECH INC
EFT EATON VANCE FLOATING RATE INCOME TRUST
BRKB BERKSHIRE HATHAWAY INC.
NMTR INNOVATE BIOPHARMACEUTICALS
RILY INC.
ATHA B. RILEY FINANCIAL
ELYS ATHIRA PHARMA
DLHC ELYS GAME TECHNOLOGY
CURI DALEIGH HOLDINGS CORP
KEQU CURIOSITYSTREAM INC (A)
UTZ KEWAUNEE SCIENTIFIC CORP.
TURN UTZ BRANDS INC (A)
YAYO 180 DEGREE CAPITAL
RIDESHARE RENTAL INC
- Jonathan Moreland
PBF PBF ENERGY INC. CLASS A
NRC NATIONAL RESEARCH CORPORATION
NPTN NEOPHOTONICS
JKHY JACK HENRY & ASSOCIATES INC.
IEP ICAHN ENTERPRISES L.P.
CTMX CYTOMX THERAPEUTICS INC.
CLR CONTINENTAL RESOURCES INC.
ALDX ALDEYRA THERAPEUTICS
CERC CERECOR INC
CQP CHENIERE ENERGY PARTNERS L.P.
TRUE TRUECAR INC.
AIRT AIR T INC.
UIHC UNITED INSURANCE HOLDINGS CORP.
PLSE PULSE BIOSCIENCES
SPLP STEEL PARTNERS HOLDINGS LP LTD.
HOME AT HOME GROUP INC.
CLSD CLEARSIDE BIOMEDICAL INC
GBDC GOLUB CAPITAL BDC INC.
MRUS MERUS B V
REVG REV GROUP INC.
ESTE EARTHSTONE ENERGY
CLRB CELLECTAR BIOSCIENCES
ALRN AILERON THERAPEUTICS
ODT ODONATE THERAPEUTICS INC
ROOT ROOTS
MVBF MVB FINANCIAL CORP
OFG ORIENTAL FINANCIAL GROUP
NJMC INC.
GRTS NEW JERSEY MINING CO.
VTA GRITSTONE ONCOLOGY
KFS INVESCO DYNAMIC CREDIT OPPORTU
MIRM KINGSWAY FINANCIAL SERVICES
TCON MIRUM PHARMACEUTICALS
DMTK TRACON PHARMACEUTICALS
EFT DERMTECH INC
EYEG EATON VANCE FLOATING RATE INCOME TRUST
BRKB EYEGATE PHARMACEUTICALS
CLSK BERKSHIRE HATHAWAY INC.
RILY CLEANSPARK
EGLE B. RILEY FINANCIAL
UTZ EAGLE BULK SHIPPING
SCYX UTZ BRANDS INC (A)
DNMR SCYNEXIS INC
MVEN DANIMER SCIENTIFIC
WISH INC.
MDVL THEMAVEN
ESOA INC.
TURN WRIGHT INVESTORS SERVICE HOLDINGS
SOBR INC.
MYOS RENS TECHNOLOGY INC.
ENERGY SERVICES OF AMERICA CORP.
180 DEGREE CAPITAL
SOBR SAFE
INC.
- Jonathan Moreland
REI RING ENERGY INC.
PBF PBF ENERGY INC. CLASS A
MACK MERRIMACK PHARMACEUTICALS INC
LXRX LEXICON PHARMACEUTICALS INC.
LOB LIVE OAK BANCSHARES
GTIM GOOD TIMES RESTAURANTS INC
CTMX CYTOMX THERAPEUTICS INC.
CLR CONTINENTAL RESOURCES INC.
CCI CROWN CASTLE INTERNATIONAL CORP
CQP CHENIERE ENERGY PARTNERS L.P.
MBII MARRONE BIO INNOVATIONS INC
WRLD WORLD ACCEPTANCE CORPORATION
AIRT AIR T INC.
UIHC UNITED INSURANCE HOLDINGS CORP.
CTHR CHARLES & COLVARD LTD.
PLSE PULSE BIOSCIENCES
SPLP STEEL PARTNERS HOLDINGS LP LTD.
HOME AT HOME GROUP INC.
GBDC GOLUB CAPITAL BDC INC.
MRUS MERUS B V
CLRB CELLECTAR BIOSCIENCES
VST VISTRA CORP.
CNNE CANNAE HOLDINGS
ODT ODONATE THERAPEUTICS INC
MBIO MUSTANG BIO
CNX CONSOL ENERGY INC.
VBFC VILLAGE BANK AND TRUST FINANCIAL
KRMD REPRO MED SYSTEMS
GTXMQ GARRETT MOTION INC.
ARVN ARVINAS HOLDING
VTA INVESCO DYNAMIC CREDIT OPPORTU
KFS KINGSWAY FINANCIAL SERVICES
USIO USIO INC
LSYN LIBERATED SYNDICATION
TCON TRACON PHARMACEUTICALS
EFT EATON VANCE FLOATING RATE INCOME TRUST
BRKB BERKSHIRE HATHAWAY INC.
BCSF BAIN CAPITAL SPECIALTY FINANCE
PROG PROGENITY
NMTR INC.
ATCX INNOVATE BIOPHARMACEUTICALS
SNEX INC.
MPLN ATLAS TECHNICAL CONSULTANTS INC (A)
CRTD STONEX GROUP INC
ELYS MULTIPLAN CORP CLASS A
DLHC CREATD
CURI ELYS GAME TECHNOLOGY
KEQU DALEIGH HOLDINGS CORP
EGLE CURIOSITYSTREAM INC (A)
UTZ KEWAUNEE SCIENTIFIC CORP.
SCYX EAGLE BULK SHIPPING
TURN UTZ BRANDS INC (A)
SCYNEXIS INC
180 DEGREE CAPITAL
- Jonathan Moreland
PNNT PENNANTPARK INVESTMENT
NPTN NEOPHOTONICS
MG MISTRAS GROUP
LXRX LEXICON PHARMACEUTICALS INC.
LQDT LIQUIDITY SERVICES
LOB LIVE OAK BANCSHARES
JKHY JACK HENRY & ASSOCIATES INC.
GTIM GOOD TIMES RESTAURANTS INC
GME GAMESTOP CORP. CLASS A
FL FOOT LOCKER INC.
CTMX CYTOMX THERAPEUTICS INC.
ACTG ACACIA RESEARCH CORP. - ACACIA TECHNOLOGIES
MBII MARRONE BIO INNOVATIONS INC
INBK FIRST INTERNET BANCORP
AIRT AIR T INC.
UIHC UNITED INSURANCE HOLDINGS CORP.
PLSE PULSE BIOSCIENCES
SPLP STEEL PARTNERS HOLDINGS LP LTD.
MRUS MERUS B V
ATH ATHENE HOLDING LTD. CLASS A
CLRB CELLECTAR BIOSCIENCES
VST VISTRA CORP.
TURN 180 DEGREE CAPITAL
ODT ODONATE THERAPEUTICS INC
MBIO MUSTANG BIO
MVBF MVB FINANCIAL CORP
OFG ORIENTAL FINANCIAL GROUP
AQB INC.
BFGCD AQUABOUNTY TECHNOLOGIES
GTXMQ BULLFROG GOLD
ARVN GARRETT MOTION INC.
VTA ARVINAS HOLDING
USIO INVESCO DYNAMIC CREDIT OPPORTU
MCFT USIO INC
MIRM MASTERCRAFT BOAT HOLDINGS
TCON MIRUM PHARMACEUTICALS
EFT TRACON PHARMACEUTICALS
GDYN EATON VANCE FLOATING RATE INCOME TRUST
SNEX GRID DYNAMICS HOLDINGS
EOSE INC.
DLHC STONEX GROUP INC
CURI EOS ENERGY ENTERPRISES INC (A)
KEQU DALEIGH HOLDINGS CORP
CSQ CURIOSITYSTREAM INC (A)
EGLE KEWAUNEE SCIENTIFIC CORP.
UTZ CALAMOS STRATEGIC TOTAL RETURN FUND
TRCH EAGLE BULK SHIPPING
SCYX UTZ BRANDS INC (A)
DNMR POLE PERFECT STUDIOS INC
SCYNEXIS INC
DANIMER SCIENTIFIC
INC.
- Jonathan Moreland
TESS TESSCO TECHNOLOGIES INC.
SYNL SYNALLOY CORP.
SREV SERVICESOURCE INTERNATIONAL INC.
REED REEDS INC.
RAVE RAVE RESTAURANT GROUP
MG MISTRAS GROUP
MACK MERRIMACK PHARMACEUTICALS INC
GTIM GOOD TIMES RESTAURANTS INC
CVCY CENTRAL VALLEY COMMUNITY BANCORP
CTG COMPUTER TASK GROUP INC.
ACTG ACACIA RESEARCH CORP. - ACACIA TECHNOLOGIES
FTK FLOTEK INDUSTRIES INC.
MBII MARRONE BIO INNOVATIONS INC
SPOK SPOK HOLDINGS
ESP ESPEY MANUFACTURING & ELECTRONICS CORP.
UIHC UNITED INSURANCE HOLDINGS CORP.
CTHR CHARLES & COLVARD LTD.
CLRB CELLECTAR BIOSCIENCES
TURN 180 DEGREE CAPITAL
MBIO MUSTANG BIO
BOXL BOXLIGHT CLS A
VBFC VILLAGE BANK AND TRUST FINANCIAL
ISNS IMAGE SENSING SYSTEMS INC.
LAZY LAZYDAYS HOLDINGS
NHLD NATIONAL HOLDINGS
BFGCD BULLFROG GOLD
RGLS REGULUS THERAPEUTICS
USIO USIO INC
BW BABCOCK & WILCOX ENTERPRISES
LSYN LIBERATED SYNDICATION
TCON TRACON PHARMACEUTICALS
PSTI PLURISTEM THERAPEUTICS INC
DCTH DELCATH SYSTEMS
CVLB CONVERSION LABS
NMTR INC.
ATCX INNOVATE BIOPHARMACEUTICALS
FSLF INC.
FTSI ATLAS TECHNICAL CONSULTANTS INC (A)
BSPK THL CREDIT SENIOR LOAN FUND
COHN FTS INTERNATIONAL INC. CLASS A
CRTD BESPOKE EXTRACTS
ELYS INC.
DLHC COHEN AND COMPANY
KEQU CREATD
EGLE ELYS GAME TECHNOLOGY
TRCH DALEIGH HOLDINGS CORP
SCYX KEWAUNEE SCIENTIFIC CORP.
EAGLE BULK SHIPPING
POLE PERFECT STUDIOS INC
SCYNEXIS INC
- Jonathan Moreland
CTMX CYTOMX THERAPEUTICS INC.
UIHC UNITED INSURANCE HOLDINGS CORP.
CNBKA CENTURY BANCORP INC. CL A
CLRB CELLECTAR BIOSCIENCES
OFG ORIENTAL FINANCIAL GROUP
GIM INC.
FIXX TEMPLETON GLOBAL INCOME FUND
VTA HOMOLOGY MEDICINES
MIRM INVESCO DYNAMIC CREDIT OPPORTU
TCON MIRUM PHARMACEUTICALS
EFT TRACON PHARMACEUTICALS
FSLF EATON VANCE FLOATING RATE INCOME TRUST
THL CREDIT SENIOR LOAN FUND
- Jonathan Moreland
USAK USA TRUCK INC.
SANW S&W SEED CO
NRIM NORTHRIM BANCORP INC.
KIRK KIRKLAND'S INC.
HT HERSHA HOSPITALITY TRUST CLASS A
HRZN HORIZON TECHNOLOGY FINANCE CORP.
HCHC HC2 HOLDINGS INC.
GTIM GOOD TIMES RESTAURANTS INC
FOSL FOSSIL GROUP INC.
ESCA ESCALADE INC.
VPA1 AVEO PHARMACEUTICALS INC.
ACRX ACELRX PHARMACEUTICALS
ACBI ATLANTIC CAPITAL BANCSHARES
MLVF MALVERN BANCORP
OPRX OPTIMIZERX CORP
KODK EASTMAN KODAK CO
CCRN CROSS COUNTRY HEALTHCARE INC.
CERC CERECOR INC
CCV COUNTERPATH
FLXS FLEXSTEEL INDUSTRIES INC.
EMCF EMCLAIRE FINANCIAL CORP.
ZDGE ZEDGE
SIF SIFCO INDUSTRIES
JAX J. ALEXANDER'S HOLDINGS
CDEV CENTENNIAL RESOURCE DEVELOPMENT INC. CLASS A
CLRB CELLECTAR BIOSCIENCES
ALRN AILERON THERAPEUTICS
HHS HARTE-HANKS INC.
TMRC TEXAS MINERAL RESOURCES CORP
KZR KEZAR LIFE SCIENCES
ANIX ANIXA BIOSCIENCES
FGBI FIRST GUARANTY BANCSHARES
WLMS WILLIAMS INDUSTRIAL SERVICES GROUP INC.
BCDA BIOCARDIA
MWK MOHAWK GROUP HOLDINGS
BW BABCOCK & WILCOX ENTERPRISES
BCML BAYCOM
SONM SONIM TECHNOLOGIES
SIC SELECT INTERIOR CONCEPTS
MCACU MOUNTAIN CREST ACQUISITION CORP.
BRBS BLUE RIDGE BANKSHARES
YAYO YAYYO
TTI ROPER BROTHERS INC
SUME SUMMER ENERGY HOLDINGS
HYSR HYPERSOLAR INC
- Jonathan Moreland
TXMD THERAPEUTICSMD INC.
SANW S&W SEED CO
PNFP PINNACLE FINANCIAL PARTNERS INC.
ORI OLD REPUBLIC INTERNATIONAL CORPORATION
4LT1 NORTHERN OIL & GAS INC.
LQDT LIQUIDITY SERVICES
FOSL FOSSIL GROUP INC.
FGEN FIBROGEN INC.
EXTR EXTREME NETWORKS INC.
AVID AVID TECHNOLOGY INC.
ATO ATMOS ENERGY CORPORATION
ASB ASSOCIATED BANC-CORP
AMRS AMYRIS
AMG AFFILIATED MANAGERS GROUP INC.
ADS ALLIANCE DATA SYSTEMS CORPORATION
AMWD AMERICAN WOODMARK CORPORATION
CERC CERECOR INC
CNA CNA FINANCIAL CORPORATION
CCV COUNTERPATH
FLXS FLEXSTEEL INDUSTRIES INC.
LSXMA LIBERTY MEDIA CORP. SERIES A LIBERTY SIRIUSXM
RILY B RILEY SECURITIES INC
CNBKA CENTURY BANCORP INC. CL A
CWH CAMPING WORLD HOLDINGS INC. CLASS A
PHD PIONEER FLOATING RATE
CDEV CENTENNIAL RESOURCE DEVELOPMENT INC. CLASS A
MRUS MERUS B V
ATH ATHENE HOLDING LTD. CLASS A
CLRB CELLECTAR BIOSCIENCES
KALA KALA PHARMACEUTICALS INC.
ALRN AILERON THERAPEUTICS
RCUS ARCUS BIOSCIENCES
MNLO MENLO THERAPEUTICS INC
BHC BAUSCH HEALTH COMPANIES INC.
KZR KEZAR LIFE SCIENCES
ETTX ENTASIS THERAPEUTICS HOLDINGS
REZI RESIDEO TECHNOLOGIES
KLDO INC.
APRN KALEIDO BIOSCIENCES
BW BLUE APRON HOLDINGS
WTRE BABCOCK & WILCOX ENTERPRISES
ARCT WATFORD HOLDINGS
CHNG ARCTURUS THERAPEUTICS HOLDINGS INC
LSXMK CHANGE HEALTHCARE INC.
EVF LIBERTY MEDIA CORP. SERIES C LIBERTY SIRIUSXM
CLDX EATON VANCE SENIOR INCOME TRUST
APDN CELLDEX THERAPEUTICS INC.
SONM APPLIED DNA SCIENCES INC.
BCSF SONIM TECHNOLOGIES
CRDB BAIN CAPITAL SPECIALTY FINANCE
SIC CRAWFORD & COMPANY
MCACU SELECT INTERIOR CONCEPTS
MOUNTAIN CREST ACQUISITION CORP.
- Jonathan Moreland
LQDT LIQUIDITY SERVICES
GTIM GOOD TIMES RESTAURANTS INC
EXTR EXTREME NETWORKS INC.
AVID AVID TECHNOLOGY INC.
LSXMA LIBERTY MEDIA CORP. SERIES A LIBERTY SIRIUSXM
CWH CAMPING WORLD HOLDINGS INC. CLASS A
SOR SOURCE CAPITAL INC.
CDEV CENTENNIAL RESOURCE DEVELOPMENT INC. CLASS A
VERI VERITONE INC.
CLRB CELLECTAR BIOSCIENCES
RCUS ARCUS BIOSCIENCES
REZI RESIDEO TECHNOLOGIES
KLDO INC.
WTRE KALEIDO BIOSCIENCES
BCSF WATFORD HOLDINGS
BAIN CAPITAL SPECIALTY FINANCE
Cellectar Biosciences to Present at the Biotech Showcase
Cellectar Biosciences to Present at the Biotech Showcase FLORHAM PARK, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments for cancer, announces that James Caruso, president and chief executive officer of Cellectar Biosciences, will present a company overview at the Biotech Showcase on Monday, January 7, 2019 at 10:00am Pacific Time. The conference will be held at the Hilton San Francisco Union Square January 7-9, 2019. A liv...
Cellectar Granted Japanese Patent for CLR 131
Cellectar Granted Japanese Patent for CLR 131 Patent covers composition of matter and use in solid and liquid tumor cancer indications FLORHAM PARK, N.J., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments for cancer, announces that the Japan Patent Office has granted the patent titled “Phospholipid Analogs as Diapeutic Agents and Methods of Use Thereof” with application number 2016135920. The patent provides composition of matter and ...
Cellectar Initiates Cohort 6 of Phase 1b Trial Evaluating CLR 131 in R...
Cellectar Initiates Cohort 6 of Phase 1b Trial Evaluating CLR 131 in Relapsed/Refractory Multiple Myeloma Patient enrolled at highest fractionated two-dose regimen to date FLORHAM PARK, N.J., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, announces the initiation of Cohort 6 of its ongoing Phase 1b trial evaluating CLR 131 for the treatment of relapsed/refractory (R/R) multiple myeloma (MM). Cohort 6 will evaluate up to fou...
Cellectar Reports Third Quarter 2018 Financial Results and Provides Bu...
Cellectar Reports Third Quarter 2018 Financial Results and Provides Business Update FLORHAM PARK, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB) (“Cellectar” or “the Company”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today reported financial results for the three and nine months ended September 30, 2018 and provided a business update. Third Quarter 2018 and Recent Highlights Announced that the U.S. Food and Drug Administration has granted an exemption ...
Cellectar Announces FDA Grants Exemption to Import Alert for CLR 131 H...
Cellectar Announces FDA Grants Exemption to Import Alert for CLR 131 Hematology Studies Clinical Trials to Advance Across Multiple Hematology Programs FLORHAM PARK, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, announces today that the U.S. Food and Drug Administration (FDA) has granted an exemption to the Import Alert placed on the Centre for Probe Development and Commercialization (CPDC), the sole supplier of ...
Cellectar Announces Overall Survival Exceeding 19 Months in Phase 1b T...
Cellectar Announces Overall Survival Exceeding 19 Months in Phase 1b Trial with CLR 131 in Relapsed/Refractory Multiple Myeloma MADISON, Wis., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today updates interim overall survival (OS) data from the company’s ongoing Phase 1b clinical trial evaluating CLR 131 for the treatment of relapsed/refractory (R/R) multiple myeloma (MM). The results to date show that OS is currently at...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.